Our Vision
Our goal is to provide non-invasive solutions to the various challenges in the cardiovascular field. These range from Hypertension, Chronic heart failure, Hemodialysis, ICU/ICCU, Neonatal, Obstetrics & Gynecology, and treatment of infectious diseases.
The NI Medical NICaS System provides a much-needed solution for non-invasive hemodynamic and fluid management in both inpatient and outpatient settings.
Our History
Our Team
Eyal Hahn has extensive experience in international business development and mergers and acquisitions (M&A). He served as Chairman & CEO of Bateman-Litwin (AIM: BNLN and was the former Director at Deutsche Bank’s M&A unit.
Igor Granov is the inventor of NI Medical’s unique algorithm for the detection of LVSD. He has vast experience in the international medical device market, Impedance Cardiography technology, and extensive knowledge in regulatory affairs.
He is a partner in NI Medical’s patent registration and has a broad knowledge of inpatient clinical settings as a bio-impedance researcher.
Prof. Zvi Vered is the Former president of the Israeli Cardiology Society. He served in numerous
senior positions in both Israel and abroad. Prof. Vered is the former Director of Cardiology DPT.
at Assaf Harofeh Medical Center and a professor of medicine at the Sackler Faculty of Medicine – Tel-Aviv. Currently, Prof. Vered is the director of the cardiology department at Maccabi health care services and the medical director of NI Medical.
Evegeny Granov is the inventor of NI Medical’s platform. He has rich experience in analog and digital equipment development.
Shany is a B.Sc graduate in Polymer Engineering and M.Sc graduate in Technology Management. Shany has experience in both R&D; Project Management and global Account Management in the Medical Device industry.
Yuri Livshits has an in depth experience designing and implementing of multi system platforms using various S/W methodologies.
Advisory Board
John GF Cleland MD, PhD, FRCP, FESC, FACC
Professor Cleland is a Cardiologist and Director of the Robertson Centre for Biostatistics Clinical Trials (University of Glasgow) and Visting Professor of Cardiology (Imperial College London).
Previous appointments include Senior Lecturer, Royal Postgraduate Medical School, Hammersmith Hospital and Professor of Cardiology at the University of Hull.
He helped found the European Society of Cardiology’s (ESC) Task Force on Heart Failure, founded the European Journal of Heart Failure and co-wrote several ESC guidelines. Special interests are diagnostic criteria and epidemiology of heart failure (a cardio-renal syndrome) and randomized trials for preventing and treating heart failure. He is a Clarivate highly-cited researcher.
Dr. Marat Fudim is a heart failure cardiologist at the Duke University Medical Center. He completed his medical school in Germany, residency at Vanderbilt and cardiology fellowship at Duke. He currently serves as the Medical Director for the Heart Failure Research Unit, and Heart Failure Remote Monitoring.
Paul Alan Sobotka, M.D., F.A.C.P., F.A.C.C. F.A.H.A , matriculated from Stanford University with degree in Chemistry and obtained MD from the University of Illinois College of Medicine. He currently holds an appointment as Clinical Professor of Medicine/Cardiology at The Ohio State University. Dr. Sobotka has authored 200 peer reviewed manuscripts and book chapters including manuscripts published in: The Journal Clinical Investigation, American Journal of Physiology, The New England Journal of Medicine, Lancet and many more.
Prof. Bhandari graduated from the University of Edinburgh, trained in Renal and Transplant Medicine in Yorkshire (UK) and Sydney Australia. He is a Consultant in Nephrology and Honorary Professor at Hull York Medical School (HYMS) and Hull University Teaching Hospitals NHS Trust. He is the Co-Director of UK Advanced Nephrology Course, Deputy Head of School of Medicine for Yorkshire and Humber, the Vice President for Royal College of Physicians Edinburgh (RCPE) and the CO Chair of UK Kidney Research Consortium.
Dr. Kevin Jackson completed his medical school in Columbia University, his residency in
University of California San Francisco and Fellowship at Duke University School of Medicine.
His Research interests include: optimization of device timing for cardiac resynchronization therapy (CRT), novel cardiac imaging technologies for CRT, catheter ablation versus anti-arrhythmic drug for treatment of atrial fibrillation.
Dr. Daniel J Friedman completed his medical school at Cornell University, his internal medicine residency at Massachusetts General Hospital, and fellowships in cardiovascular diseases and clinical cardiac electrophysiology at Duke University Hospital. He is board certified in Clinical Cardiac Electrophysiology.
Prof. Frankenstein underwent undergraduate training in Jena, Germany (FSU), London, Great Britain (St. George’s Hospital Medical School), and Orléans, France (Université de Tours). He then trained in Cardiology in Heidelberg, Germany. He holds a degree in health economics from the London School of Economics, London, Great Britain. He currently is a Consultant in Cardiology at the University Hospital Heidelberg. He is the Leader of the Heart Failure Outpatients’ Department, Co-Chair of the Rhein-Neckar-Collaborative Heart Failure register, Leader of the Reimbursement Committee of the German Cardiac Society.
Prof. Frankenstein leads research programs based on Chronic Heart Failure and many more.
Prof. Zvi Vered is the Former president of the Israeli Cardiology Society. He served in numerous senior positions in both Israel and abroad. Prof. Vered is the former Director of Cardiology DPT.
at Assaf Harofeh Medical Center and a professor of medicine at the Sackler Faculty of Medicine – Tel-Aviv. Currently, Prof. Vered is the director of the cardiology department at Maccabi health care services and the medical director of NI Medical.
Board of Directors
Eyal Hahn has extensive experience in international business development and mergers and acquisitions (M&A). He served as Chairman & CEO of Bateman-Litwin (AIM: BNLN and was the former Director at Deutsche Bank’s M&A unit.
Barbara Faktor has many years of experience in hospital management and medical device start-ups in Israel. she was the founder and director of Medcon, sold to Mkeeson. She also served as Director at Dmatek, sold to Francisco Partners and Director at Oridion, sold to Covidien. Presently, she is an active director at Lunguard and NI Medical; and CEO of Rishonim Medical Center.
Adi Livneh has a very solid background in managing large international enterprises.
He has served as the CEO of four international companies, with annual revenues ranging from $70M to $150M.
Prof. Goor received his MD degree from the Jerusalem University in 1962. Head of Cardiac Surgery at the Sheba Medical center, University of Tel Aviv, Israel 1976-1996. Head of Cardiac Surgery at Ramat Marpe Clinic 1990-2001. Associate Professor in 1974, Professor of Surgery in 1986, and Head of the Pionkowsky Chair of Cardiac Surgery at the Tel Aviv University until retirement. President of the Israel Association of Thoracic and CV Surgery 1985-1992. Co-author of two books, Congenital Malformations of the Heart (Grune & Stratton 1975), and Management of Bleeding after Open-Heart Surgery (Landes Bioscience and Springer 1997), and author of “The Genius of C. Walton Lillehei and the true history of Open Heart Surgery”, as well as 120 medical scientific papers.
Our Memberships
NI Medical is a Member of the American Heart Association’s Innovators’ Network.
Contact Us
